I. Pa, N. R, N. R, B. Ing, and T. K, “DIFFERENCE IN BLOOD FUNCTION TOXICITY BETWEEN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WITH PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL, DENPASAR”., Asian J Pharm Clin Res, vol. 11, no. 1, pp. 224–227, Jan. 2018.